988 Results
Older Americans Month: Highlighting Challenges and Opportunities
An estimated one in eight older adults had a mental illness and one in 11 had a substance use disorder in the past year according to a new report on mental health and substance use concerns among older adults (adults aged 60 or older).
APA Urges Congress to Fund Mental Health and Substance Use Disorder Provisions Within the Build Back Better Act
As Congress considers a reconciliation package to address funding President Biden’s Build Back Better Act, the American Psychiatric Association (APA) is expressing strong support for several provisions within the Act that are critical for enhancing efforts to improve mental health across the nation at this time of great need. In a letter sent to House and Senate leadership, the APA detailed essential provisions to include within the package
American Psychiatric Association Announces Launch of PsychPRO 2.0 Mental Health Registry
The American Psychiatric Association (APA) announced today the launch of PsychPRO 2.0, a next-generation technology platform for the PsychPRO mental health registry offering enhanced options for engaging with patients, tracking outcomes, and streamlined data collection for quality reporting.
Participating in Social Groups to Help Manage Depression
Participation in social groups may be an effective way to manage mild to moderate depression, according to a new study from researchers at The University of Queensland, Australia. It can be especially for useful for people seeking to stop using antidepressants, they note.
APA Applauds Administration for Issuing Final Rules on Mental Health Parity
The American Psychiatric Association applauds the Biden-Harris Administration for issuing final rules to strengthen the 2008 Mental Health Parity and Addiction Equity Act (MHPAEA) and improve access to quality care for mental health and substance use disorders. The rules, issued by the Departments of Labor, Treasury, and Health and Human Services, reinforce that insurance plans must analyze and document limits to mental health and substance use disorders benefits, and ensure they are no more res
New Book Issues Wake-up Call on Technology Addiction
A new book from APA Publishing, Technological Addictions, is a wake-up call alerting the medical community—and society at large—to the addictive potential of technology. Edited by Petros Levounis, M.D., M.A., and James Sherer, M.D., the book provides context and understanding around potential addiction to a variety of technologies, along with discussion of assessment, diagnosis and treatment.
Mental Health Concerns in E-Sport Athletes: Lessons from a Legend
Lee Sang-Hyeok is probably the most famous e-sport athlete of all time. Better known as his gamer name “Faker,” he is the most dominant League of Legends player in history, with a total of four world championship titles. His incredible success can be attributed to not only his work ethic, but also the massive infrastructure in place around him, including an enormous training center built in Seoul, Korea by his team T1 Esports. Even with access to some of the best resources the industry has to of
The Carbon Footprint of Cancelling the APA, a Virtual Match, and More: Impacts of Psychiatric Activity on Global Warming
This episode features an excerpt from the presentation, " The Carbon Footprint of Cancelling the APA, a Virtual Match, and More: Impacts of Psychiatric Activity on Global Warming" by Dr. Elizabeth Haase.
Brain Imaging Shows the Impacts of Psychotherapy
Psychotherapy, or talk therapy, is an effective treatment for many mental health disorders. Advances in brain imaging are increasingly allowing researchers to observe the changes in the brain resulting from psychotherapy treatment.
The Unequal Impact of the Opioid Epidemic in the African American Community: Insights for Psychiatrists
This panel will unpack the complexities of the unequal impact of opioids in the African American community and evaluate the role of implicit bias.
FDA Approves Novel Depression Treatment
Last month, esketamine nasal spray became the first treatment for depression with a new mechanism of action approved by the Food and Drug Administration (FDA) since Prozac (fluoxetine hydrochloride) was approved in the late 1980s. Esketamine (sold as Spravato) has the potential to be extremely useful for people who have not responded to other treatments. Used in combination with an oral anti-depressant, it can take effect much faster than many common antidepressant medications. However, it comes
New Research: Coaching Healthcare Workers Supports Wellness and Resilience During COVID-19
During the COVID-19 pandemic, healthcare workers face unprecedented challenges that pose a threat to mental health and resilience. A preliminary assessment of a program of coaching for healthcare workers, presented at the American Psychiatric Association’s Annual Meeting, held online, finds it is effective in supporting workers’ wellness and resilience.